Can You Get Life Insurance with a Medical Cannabis Prescription? (UK Guide)

You did everything properly. You saw a specialist, got a legal prescription, and your medicine arrives from a licensed pharmacy. Then you sit down to apply for life insurance and hit the question: "Have you used cannabis in the last five years?"

This guide explains exactly how UK insurers treat prescribed cannabis, what happens after you tick "yes", and how to get the best outcome.

The short answer

UK life insurers can and do cover medical cannabis patients. Since cannabis-based products for medicinal use (CBPMs) became legal to prescribe in November 2018, insurers have developed underwriting approaches for prescribed patients — and several treat a valid prescription very differently from recreational use.

Some insurers have publicly set out their position. Zurich, for example, has stated that where a doctor confirms cannabis is prescribed for a medical condition and isn't smoked, the customer is assessed normally with no additional rating or exclusion for the cannabis itself — but if it's smoked, or there's no valid prescription, the applicant is assessed like any other cannabis smoker. That single policy captures the two things that matter most across the market: prescription status and route of administration.

Why disclosure is non-negotiable

Under the Consumer Insurance (Disclosure and Representations) Act 2012, you have a legal duty to take reasonable care not to make a misrepresentation when answering an insurer's questions. Answer falsely — or leave out something they asked about — and the insurer can reduce or refuse a claim, or treat the policy as if it never existed.

This isn't theoretical. Non-disclosure is consistently among the most common reasons UK life insurance claims are rejected. And cannabis is unusually easy to discover: it appears in your clinic records, your pharmacy records, and in any blood or urine test the insurer requests. Insurers can and do test for cannabis alongside other substances during medical underwriting.

The brutal irony for patients: the prescription that makes your cannabis use insurable is the same paper trail that makes hiding it impossible. Disclose it, and it works in your favour. Hide it, and your family may get nothing.

Rule of thumb: answer every question truthfully and completely, attach context where the form allows ("prescribed by [specialty] consultant for [condition], oil/capsule, no smoking"), and keep copies of what you submitted.

What insurers actually assess

When you disclose a prescription, underwriters typically look at four things, roughly in this order of importance:

1. The underlying condition

This is usually the biggest factor — often bigger than the cannabis itself. Insurers price the mortality and morbidity risk of the condition you're being treated for: chronic pain, anxiety, PTSD, epilepsy, MS. A patient prescribed for well-managed chronic pain is a different risk from a patient with a complex neurological condition, and premiums reflect that. Several UK insurers have said openly that medicinal cannabis use is usually acceptable in itself, with cases assessed individually on the underlying condition.

Prescribed for a mental health condition? Full disclosure guide coming soon.

2. How you take it

Oils, capsules and other non-inhaled formats are viewed most favourably. Smoked cannabis — even prescribed — typically pushes you into smoker rates, which can roughly double a premium. Vaporised flower sits in a grey zone that varies insurer to insurer. If you use oil or capsules only, say so explicitly; some insurers will offer non-smoker terms.

3. Prescription evidence

A valid prescription from a UK specialist, a named condition, and specialist oversight transform how your use is categorised — from "drug use" to "prescribed medication". Expect the insurer to ask for prescription details and possibly a report from your prescriber or GP. Make sure your GP knows about your private prescription before you apply: an underwriter finding a prescription your GP records don't mention creates exactly the inconsistency you don't want.

4. Frequency, dose and history

Recent, heavy or escalating use draws more questions than a stable, titrated dose. Previous recreational use before your prescription may also be asked about — answer honestly; historic use matters much less than current patterns.

What it costs

There's no single answer, but the realistic range looks like this:

• Best case: oil/capsule patient, stable well-managed condition, non-smoker — standard or near-standard rates with some insurers.
• Middle: a premium loading driven by the underlying condition, not the cannabis.
• Smoked/vaped flower: expect smoker rates as the starting point.
• Complex conditions: individual underwriting; outcomes vary widely between insurers for the same diagnosis.

Because insurer appetite varies this much, where you apply matters as much as what you disclose. A specialist broker who knows which underwriters handle CBPM patients sensibly will usually beat a comparison site — and avoids the decline-spiral described below.

If you've been declined

A decline is not the end, but what you do next matters. Every mainstream application asks whether you've previously been declined, so firing off more direct applications compounds the problem. The specialist broker route exists precisely for cases like this.

Already insured, then prescribed?

Life insurance is underwritten at the point of application. If your prescription started after your policy did, you generally have no duty to notify your insurer mid-term — but check your policy documents for any ongoing notification clauses, and remember the position resets the moment you apply for new or increased cover.

A note on health insurance

Different product, different answer: UK private medical insurance does not generally cover the cost of medical cannabis treatment itself, which is typically an outpatient, chronic-condition expense that PMI policies aren't designed for. This guide covers protection products — life cover, and by extension critical illness and income protection.